Insights From An Integrated Psychology and Dermatology Service: Small Steps Towards More Psychologically Centred Care For All Dermatology Patients

Wednesday 6th December 2023

Session time: 18:30 – 19:30

Summary of the webinar:
The webinar will consider the importance of psychological centred care to support Dermatology patients. Dr Sandy McBride and Dr Alexandra Mizara will provide practical advice on how to provide psychologically centred care, without a psychologist and how to effectively manage emotion in busy clinics. This meeting has been developed, organised and funded by Eli Lilly and Company. Lilly products will be discussed at this meeting.

---

Dr Sandy McBride is a consultant dermatologist with a special interest in psoriasis and the psychological impact of skin conditions. As well as performing general dermatology, she leads a multi-disciplinary psoriasis service which aims to provide holistic care to people with psoriasis. She is also dermatology lead for the Royal Free psycho-dermatology service, a member of the British Association of Dermatologists psycho-dermatology working party and the See Psoriasis: Look Deeper collaboration. Her research interests include the management of psoriasis and the psychological impact of psoriasis and other skin diseases.

Dr Alexandra Mizara is a Chartered Counselling Psychologist and works in both the private sector and NHS in the UK. She has a specialist interest in psychodermatology, and has set up with Dr Sandy McBride a pioneering psychology-dedicated service for patients with skin conditions in a teaching hospital, Royal Free Hospital NHS Foundation Trust, in London. Her research interests lie in the psychological management and wellbeing of people with psoriasis, acne, alopecia areata, body image concerns and adjustment to physical change. Dr Mizara supervises doctoral theses in psychodermatology and is a keen advocate on integrating psychological care in physical health settings.

Dr Mizara has presented her research at several events, including congress of the European Academy of Dermatology and Venereology, and annual meetings of the British Association of Dermatologists. She is a chartered member of the British Psychology Society and is registered with the Health Professions Council.

Indications:
Click HERE for Taltz® (ixekizumab) Prescribing Information
Taltz is indicated for the treatment of moderate to severe plaque psoriasis in adults who
are candidates for systemic therapy.1

References:
Taltz® (ixekizumab) Summary of Product Characteristics.

Disclaimers:

This promotional webinar has been developed, organised and funded by Eli Lilly and Company. Intended for UK Healthcare Professionals only. Lilly products will be discussed in this webinar.

Please do not use this page to report adverse events. Adverse events and product complaints should be reported. Reporting forms and information can be found at UK: www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store, or Ireland: www.hpra.ie. Adverse events and product complaints should also be reported to Lilly: please call Lilly UK on 01256 315 000, or Lilly Ireland on 01 664 0446.

Taltz®and Lilly are all registered trademarks of Eli Lilly and Company.

© 2023 Eli Lilly and Company. All rights reserved.

PP-BA-GB-1909 October 2023